Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Slc38a3 Promotes The Proliferation And Migration Of Tumor Cells And Predicts Poor Prognosis In Colorectal Cancer.
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Slc38a3 Promotes The Proliferation And Migration Of Tumor Cells And Predicts Poor Prognosis In Colorectal Cancer.

Related Experiment Video

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K

SLC38A3 Promotes the Proliferation and Migration of Tumor Cells and Predicts Poor Prognosis in Colorectal Cancer.

Siyi Zhang1, Lingli Huang2, Youjie Zeng3

  • 1Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.

ACS Omega
|May 20, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

This study identifies SLC38A3 as a key transporter gene in colorectal cancer (CRC). Upregulation of SLC38A3 promotes tumor cell proliferation and migration, suggesting it as a potential therapeutic target for CRC.

More Related Videos

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

6.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

252

Related Experiment Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K
A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

6.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

252

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Abnormal expression of membrane transporters is linked to colorectal cancer (CRC) development.
  • Identifying key transporter genes is crucial for understanding CRC pathogenesis.

Purpose of the Study:

  • To conduct a comprehensive bioinformatics analysis to identify transporter protein-related genes in CRC.
  • To elucidate the role and mechanism of identified key genes in CRC progression.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) database to identify differentially expressed transporter protein-related genes (DE-TPRGs) in CRC.
  • Validated SLC38A3 expression using immunohistochemistry and RT-qPCR.
  • Investigated the functional role of SLC38A3 in HCT116 cell lines and its interaction with Hsp70.

Main Results:

  • Identified 63 DE-TPRGs, with 29 upregulated and 34 downregulated.
  • Highlighted ABCC2, ABCG2, SLC4A4, SLC9A3, SLC15A1, and SLC38A3 as significant hub genes.
  • Confirmed SLC38A3 upregulation in CRC and demonstrated that its knockdown inhibits cell proliferation and migration, a process rescued by Hsp70.

Conclusions:

  • SLC38A3 is a novel potential biomarker for colorectal cancer.
  • SLC38A3 promotes tumor cell proliferation and migration by positively regulating Hsp70 function.
  • Targeting SLC38A3 may offer a new therapeutic strategy for CRC.